Newcastle upon Tyne Hospitals NHS Foundation Trust
| Type of Trust | |
|---|---|
| NHS hospital trust | |
| Trust Details | |
| Last annual budget | |
| Employees | 13,000 |
| Chair | Kingsley Smith OBE |
| Chief Executive | Sir Leonard Fenwick CBE |
| Links | |
| Website | Newcastle Hospitals |
| Care Quality Commission reports | CQC |
| Monitor | Monitor |
Newcastle upon Tyne Hospitals NHS Foundation Trust is one of the Shelford Group of University Teaching Hospitals and an NHS Foundation Trust. It provides acute medical services in Newcastle upon Tyne, England, at Royal Victoria Infirmary and Freeman Hospital, the Campus for Ageing and Vitality (the former Newcastle General Hospital site), Newcastle Dental Hospital, Newcastle Fertility Centre and the Northern Genetics Service.
The Private Finance Initiative scheme at the Trust is a 38-year deal with Healthcare Support (Newcastle) Ltd, a special purpose vehicle formed in 2005 involving the Commonwealth Bank of Australia, Equion and Laing O'Rourke, Interserve and Innisfree Ltd. There is a dispute between the Trust and Laing O'Rourke over two clinical office buildings.
The Trust was highlighted by NHS England as having 4 (the most at any Trust) of the 148 reported never events in the period from April to September 2013.
The trust was rated outstanding by the Care Quality Commission in June 2016. It is fifth trust and first teaching hospital to be put in this category.
In December 2013 it emerged that the Trust was interested in expanding into Primary Care. Freeman Clinics, a joint venture with local GPs, was set up in 2008. There are three practices with varying ownership models − in two of them, all the GPs are salaried, while in the other, the practice’s income is shared between the trust and GP partners.
The trust has one of the 11 Genomics Medicines Centres associated with Genomics England which will open across England in February 2014. All the data produced in the 100,000 Genomes project will be made available to drugs companies and researchers to help them create precision drugs for future generations.
...
Wikipedia